Cymbalta, generic drug name duloxetine, is a dual-reuptake inhibitor of serotonin and norepinephrine approved for the treatment of major depressive disorder, the management of diabetic peripheral neuropathic pain, and generalized anxiety disorder in adults over 18 years old. Eli Lilly, the manufacturer of Cymbalta, has submitted a supplemental new drug application to the U.S. Food and Drug Administration for the management of fibromyalgia as well, based on the results of 5 clinical trials.
Cymbalta may be the next medicine FDA-approved for fibromyalgia treatment. On June 21, 2007, Lyrica (pregabalin) was approved by the FDA for treating fibromyalgia in adults 18 years and older. Until the approval of Lyrica capsules, no medicine was specifically approved for the treatment of fibromyalgia.
More Related Resources:
- Fast Facts About Fibromyalgia
- Test Your Knowledge: Fibromyalgia
- Fibromyalgia 101: Free E-Course Newsletter
- 10 Things You Should Know About Lyrica
- 10 Things You Should Know About Fibromyalgia
Join the Discussion:
Image © A.D.A.M.